Borderline epithelial ovarian tumors: a single center experience

Numanoglu C., Ulker V., Kuru O., Akbayir O., SAKINCI M., Akyol A.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, cilt.35, sa.6, ss.692-695, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 6
  • Basım Tarihi: 2014
  • Doi Numarası: 10.12892/ejgo25262014
  • Dergi Adı: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.692-695
  • Anahtar Kelimeler: Borderline ovarian tumor, Surgical staging, Clinical outcome, OF-THE-LITERATURE, RETROSPECTIVE-ANALYSIS, MALIGNANCY INDEX, SURGERY, CANCER, RISK, MANAGEMENT, BEHAVIOR, MASSES, CA-125
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Aim: To evaluate the clinical outcomes of the patients treated for borderline ovarian tumor (BOT). Materials and Methods: In this retrospective study, recoras of the patients between November 2001 and December 2012 who underwent surgery and whose final pathological diagnosis were BOT were retrieved. Results: During the study period, 78 patients were diagnosed as BOT. The pathological diagnoses of the tumors were serous in 26 (33.3%) and mucinous in 52 patients (66.6 %), respectively. Accuracy of frozen section diagnosis was observed in 63 of 89 patients (70.7%). Sixty-eight women (87.1%) underwent complete staging procedure. According to final pathological diagnoses, Stage IA, IB, and IC were found in 52 (67%), five (6.5%), and seven (9%) patients, respectively. FIGO Stages TIC and MC were found in one case in each (1.25%). Remaining 12 patients were classified as unstaged (15%). The median follow-up time was 63 months. The authors observed only one recurrence (1.3%) and that patient died of disease. Conclusion: The survival rate in patients with BOTs confmed to the ovary is excellent. Surgical staging procedure can be omitted in the patients with grossly apparent Stage I mucinous tumors.